Biodel Inc.

Biodel Inc.

Biodel Inc. company was founded in 2003 and is headquartered in Danbury, Connecticut. Biodel Inc., a development stage biopharmaceutical company, focuses on the development and commercialization of treatments for diabetes. The company develops its product candidates by utilizing its proprietary VIAdel technology that allows to study the interaction between peptide hormones and small molecules. Its product candidates include VIAject, an injectable formulation of recombinant human insulin, which has completed two pivotal Phase III clinical trials for the treatment of Type 1 and Type 2 diabetes; and VIAtab, a sublingual tablet formulation of insulin, which has completed Phase I clinical trial for Type 1 diabetes.

Contact Details

Office Address

Biodel Inc.
100 Saw Mill Road
Danbury, CT, USA 06810
Phone: (203) 796-5000
Fax: (203) 796-5001


Founder, Chairman, Chief Exec. Officer and Pres.

Mr. Solomon S. Steiner

Co-Founder and VP of Operations

Mr. Erik Steiner

Business Reviews for Biodel Inc.

Related Companies